Your browser doesn't support javascript.
loading
Efficacy of a calcium-phosphate/fluoride varnish and ionomeric sealant on cervical dentin hypersensitivity: A randomized, double-blind, placebo-controlled clinical study.
Machado, Alana Cristina; Maximiano, Vinícius; Yoshida, Mirian Lumi; Freitas, Julia Gomes; Mendes, Fausto Medeiros; Aranha, Ana Cecilia Corrêa; Scaramucci, Taís.
Afiliação
  • Machado AC; Department of Restorative Dentistry, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Maximiano V; Department of Restorative Dentistry, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Yoshida ML; Department of Restorative Dentistry, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Freitas JG; Department of Pediatric Dentistry, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Mendes FM; Department of Pediatric Dentistry, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Aranha ACC; Special Laboratory of Lasers (LELO), Department of Restorative Dentistry, School of Dentistry, University of São Paulo, São Paulo, Brazil.
  • Scaramucci T; Department of Restorative Dentistry, School of Dentistry, University of São Paulo, São Paulo, Brazil.
J Oral Rehabil ; 49(1): 62-70, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34676918
BACKGROUND: Dentin hypersensitivity (DH) is a common problem in the population that can have a significant impact on the quality of life of those who suffer from the condition. OBJECTIVES: Compare the efficacy of two treatments for DH: Ca/PO4 - /F- varnish (Clinpro White Varnish) and ionomeric sealant (IS) (Clinpro XT Varnish) with a placebo. METHODS: Participants (121) with at least one tooth with visual analogue scale (VAS) score of 4 and above were randomly and blindly allocated to the groups. Treatments were performed by a trained researcher. DH was evaluated by another blind researcher after the treatment and after 1 week, 4 weeks, 3 months and 6 months. After 4 weeks, placebo received the DH treatment with IS; thus, the participants were not assessed after 3 and 6 months. Primary outcome was DH reduction after 4 weeks. Differences in VAS scores in the other time intervals and entire values of VAS were considered secondary outcomes. Comparisons were made among the groups (α = 0.05). RESULTS: IS showed the highest VAS value difference between baseline and 4 weeks (mean ± SD: 3.7 ± 2.2), differing significantly from placebo (2.3 ± 1.7) and Ca/PO4/F- varnish (2.6 ± 2.0). Ca/PO4- /F- varnish did not differ from placebo. In all time intervals, VAS values of all groups were significantly lower than the baseline value, without differences among groups. For the long-term differences in VAS values (3 and 6 months), the IS exhibited significantly higher values than Ca/PO4- /F- varnish. CONCLUSIONS: The IS was the most efficacious product for reducing DH, whereas Ca/PO4- /F- varnish did not differ from placebo. Registered in ClinicalTrials.gov (NCT04591444).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sensibilidade da Dentina / Dessensibilizantes Dentinários Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Oral Rehabil Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sensibilidade da Dentina / Dessensibilizantes Dentinários Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Oral Rehabil Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil